Trial intelligence / Profile preview

Motilitone vs H. pylori Eradication in Functional Dyspepsia

NCT02162316Unknown

Sponsor
Chung-Ang University Hospital
Start
Jul 2014
Primary completion
Jun 2015
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of Motilitone in functional dyspepsia (FD) (2 arms), sponsored by Chung-Ang University Hospital. Primary endpoint: Volunteer global assessment of improvement rate of functional dyspepsia at 12 weeks. Status: unknown.

02

Drugs

Motilitone
03

Conditions

functional dyspepsia (FD)

Beyond the preview

Go deeper on NCT02162316.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02162316.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call